CytoDyn CYDY
OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST

CytoDyn (CYDY) Revenue (2018 - 2022)

Updated

CytoDyn (CYDY) posted Revenue of $34,000 for fiscal Q4 2022 (quarter ended May 31, 2022).

Analysis

CytoDyn (CYDY) Revenue (2018 - 2022) Analysis & Trends

For FY2022 (ended May 31, 2022), CytoDyn's Revenue came in at $300,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 CytoDyn 334.50 Mn 285.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 34,000.00
Nov 30, 2021 225,000.00
Aug 31, 2021 41,000.00
Nov 30, 2019 552,790.00
Aug 31, 2019 615,475.00
Nov 30, 2018 143,617.00
Aug 31, 2018 104,630.00
API Access

CytoDyn Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CYDY&period=max&api_key=YOUR_API_KEY